United States

QMed Inc (QMED.PK)

QMED.PK on OTC Markets Group - US Other OTC and Grey Market

12 Jul 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for QMED.PK


QMed, Inc. (QMed) is a technology formulated and interactive disease management company that synchronizes scientific evidence to insure that the right care is received by patients. The services of QMed include Online Health Management System for Cardiovascular Disease (ohms|cvd), which is an integrated cardiovascular disease... (more)
No analyst recommendations are available for QMED.PK.


Beta: --
Market Cap(Mil.): $0.00
Shares Outstanding(Mil.): 17.08
Dividend: --
Yield (%): --


  QMED.PK Industry Sector
P/E (TTM): -- 26.67 37.29
EPS (TTM): -0.39 -- --
ROI: -69.37 5.83 14.33
ROE: -70.78 9.28 15.28

BRIEF-EMC Instytut Medyczny negotiates acquisition of ACZ units

* Agrees terms of potential acquisition of 100 percent stakes in companies operating under Aktywne Centrum Zdrowia (ACZ) brand: NZOZ Zawidawie sp. z o.o., Q-Med sp. z o.o. and CM Medyk sp. z o.o.

Jul 18 2016


  Price Chg
Pfizer Inc. (PFE.N) $34.82 -0.27
Novartis AG (NOVN.S) CHF78.45 --
Roche Holding Ltd. (ROG.S) CHF243.50 --
Roche Holding Ltd. (RO.S) CHF242.40 --
GlaxoSmithKline plc (GSK.L) 1,658.50p --

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
Provider : S&P Capital IQ Quantitative Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.